サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1316751

治療薬モニタリング市場：製品、技術、薬物クラス、エンドユーザー別-2023-2030年の世界予測

Therapeutic Drug Monitoring Market by Product, Technology, Drug Class, End-User - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 184 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
治療薬モニタリング市場：製品、技術、薬物クラス、エンドユーザー別-2023-2030年の世界予測
出版日: 2023年06月12日
発行: 360iResearch
ページ情報: 英文 184 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

治療薬モニタリングの世界市場は、2023年にCAGR 16.02%で37億9,011万米ドルと予測され、2030年には驚異的な107億8,457万米ドルに達すると予測され、大きく成長すると予測されています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは世界の治療薬モニタリング市場を評価するために不可欠です。事業戦略と製品満足度の主要指標を調査することで、ベンダーの包括的な評価を提供し、ユーザーは特定のニーズに基づいた情報をもとに意思決定を行うことができます。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客基盤、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。

本レポートは、以下のポイントに関する洞察を提供します：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提供します。

2.市場の発展：有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。

3.市場の多様化：新製品の上市、未開発地域、最近の開発、投資に関する詳細情報を提供します。

4.市場の動向：COVID-19、ロシア・ウクライナ紛争、高インフレの累積的な影響を包括的に理解することができます。

5.競合の評価と情報：主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。

6.製品開発およびイノベーション：将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような質問にお答えします：

1.治療薬モニタリングの世界市場規模および予測は？

2.予測期間中、世界の治療薬モニタリング市場を形成するCOVID-19の阻害要因と影響は？

3.治療薬モニタリングの世界市場において予測期間中に投資すべき製品/セグメント/アプリケーション/分野は？

4.治療薬モニタリングの世界市場における競争戦略は？

5.治療薬モニタリングの世界市場における技術動向と規制の枠組みは？

6.治療薬モニタリングの世界市場における主要ベンダーの市場シェアは？

7.治療薬モニタリングの世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 個別化医療に対する需要の増加
      • さまざまな治療分野で治療薬モニタリングの採用が増加
      • 固形臓器移植患者における利用と重要性の増加
    • 抑制要因
      • 不適切な償還ポリシー
      • 多額の設備投資の必要性
    • 機会
      • 発展途上国における治療薬モニタリングの将来の展望
      • 免疫測定法およびその他の治療薬モニタリングテクノロジーの開発
    • 課題
      • 臨床上の課題と熟練した検査技師の不足
  • 市場動向
  • COVID-19の累積的な影響
  • ロシア・ウクライナ紛争の累積的影響
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み
  • 顧客のカスタマイズ

第6章 治療薬モニタリング市場：製品別

  • 消耗品
  • データ管理サービス
  • 装置
    • クロマトグラフィーおよびMS検出器
    • 臨床化学分析装置
    • 免疫測定分析装置

第7章 治療薬モニタリング市場：技術別

  • クロマトグラフィー-MS
    • GC-MS
    • LC-MS
  • 免疫学的検査
    • 化学発光免疫測定法
    • 比色免疫測定法
    • 蛍光免疫測定法
    • ラジオイムノアッセイ
  • プロテオミクス技術

第8章 治療薬モニタリング市場薬物クラス別

  • 抗不整脈薬
  • 抗生物質
  • 抗てんかん薬
  • 気管支拡張薬
  • 免疫抑制薬
  • 向精神薬

第9章 治療薬モニタリング市場：エンドユーザー別

  • 病院の検査室
  • プライベートラボ

第10章 南北アメリカの治療薬モニタリング市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第11章 アジア太平洋地域の治療薬モニタリング市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第12章 欧州・中東・アフリカの治療薬モニタリング市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第13章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析：主要企業別
  • 競合シナリオ分析：主要企業別
    • 契約、コラボレーション、パートナーシップ
    • 新製品発売と機能強化
    • 投資、資金調達
    • 受賞・表彰・拡大

第14章 掲載企業一覧

第15章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. THERAPEUTIC DRUG MONITORING MARKET RESEARCH PROCESS
  • FIGURE 2. THERAPEUTIC DRUG MONITORING MARKET SIZE, 2022 VS 2030
  • FIGURE 3. THERAPEUTIC DRUG MONITORING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
  • FIGURE 5. THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2022 VS 2030 (%)
  • FIGURE 6. THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2022 VS 2030 (%)
  • FIGURE 7. THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
  • FIGURE 8. THERAPEUTIC DRUG MONITORING MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 9. THERAPEUTIC DRUG MONITORING MARKET DYNAMICS
  • FIGURE 10. THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS THERAPEUTIC DRUG MONITORING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC THERAPEUTIC DRUG MONITORING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 18. THERAPEUTIC DRUG MONITORING MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 19. THERAPEUTIC DRUG MONITORING MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. THERAPEUTIC DRUG MONITORING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. THERAPEUTIC DRUG MONITORING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 5. THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DATA MANAGEMENT SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 8. THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY & MS DETECTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CLINICAL CHEMISTRY ANALYZERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAY ANALYZERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 13. THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2018-2030 (USD MILLION)
  • TABLE 14. THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. THERAPEUTIC DRUG MONITORING MARKET SIZE, BY GC-MS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. THERAPEUTIC DRUG MONITORING MARKET SIZE, BY LC-MS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
  • TABLE 18. THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. THERAPEUTIC DRUG MONITORING MARKET SIZE, BY COLORIMETRIC IMMUNOASSAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. THERAPEUTIC DRUG MONITORING MARKET SIZE, BY FLUORESCENCE IMMUNOASSAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. THERAPEUTIC DRUG MONITORING MARKET SIZE, BY RADIOIMMUNOASSAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PROTEOMIC TECHNOLOGIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 25. THERAPEUTIC DRUG MONITORING MARKET SIZE, BY ANTIARRHYTHMIC DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. THERAPEUTIC DRUG MONITORING MARKET SIZE, BY ANTIBIOTIC DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. THERAPEUTIC DRUG MONITORING MARKET SIZE, BY ANTIEPILEPTIC DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. THERAPEUTIC DRUG MONITORING MARKET SIZE, BY BRONCHODILATOR DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOSUPPRESSANT DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PSYCHOACTIVE DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. THERAPEUTIC DRUG MONITORING MARKET SIZE, BY HOSPITAL LABS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRIVATE LABS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS THERAPEUTIC DRUG MONITORING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
  • TABLE 47. ARGENTINA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 48. ARGENTINA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. BRAZIL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. BRAZIL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 51. BRAZIL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 52. BRAZIL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2018-2030 (USD MILLION)
  • TABLE 53. BRAZIL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
  • TABLE 54. BRAZIL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 55. BRAZIL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. CANADA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 57. CANADA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 58. CANADA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 59. CANADA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2018-2030 (USD MILLION)
  • TABLE 60. CANADA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
  • TABLE 61. CANADA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 62. CANADA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. MEXICO THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. MEXICO THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 65. MEXICO THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 66. MEXICO THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2018-2030 (USD MILLION)
  • TABLE 67. MEXICO THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
  • TABLE 68. MEXICO THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 69. MEXICO THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. UNITED STATES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 71. UNITED STATES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. UNITED STATES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 73. UNITED STATES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 74. UNITED STATES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2018-2030 (USD MILLION)
  • TABLE 75. UNITED STATES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
  • TABLE 76. UNITED STATES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 77. UNITED STATES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC THERAPEUTIC DRUG MONITORING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2018-2030 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. AUSTRALIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. AUSTRALIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 88. AUSTRALIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 89. AUSTRALIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2018-2030 (USD MILLION)
  • TABLE 90. AUSTRALIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
  • TABLE 91. AUSTRALIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 92. AUSTRALIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. CHINA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 94. CHINA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 95. CHINA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 96. CHINA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2018-2030 (USD MILLION)
  • TABLE 97. CHINA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
  • TABLE 98. CHINA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 99. CHINA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. INDIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. INDIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 102. INDIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 103. INDIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2018-2030 (USD MILLION)
  • TABLE 104. INDIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
  • TABLE 105. INDIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 106. INDIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. INDONESIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 108. INDONESIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 109. INDONESIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 110. INDONESIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2018-2030 (USD MILLION)
  • TABLE 111. INDONESIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
  • TABLE 112. INDONESIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 113. INDONESIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. JAPAN THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 115. JAPAN THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 116. JAPAN THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 117. JAPAN THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2018-2030 (USD MILLION)
  • TABLE 118. JAPAN THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
  • TABLE 119. JAPAN THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 120. JAPAN THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. MALAYSIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 122. MALAYSIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 123. MALAYSIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 124. MALAYSIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2018-2030 (USD MILLION)
  • TABLE 125. MALAYSIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
  • TABLE 126. MALAYSIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 127. MALAYSIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. PHILIPPINES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 129. PHILIPPINES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 130. PHILIPPINES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 131. PHILIPPINES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2018-2030 (USD MILLION)
  • TABLE 132. PHILIPPINES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
  • TABLE 133. PHILIPPINES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 134. PHILIPPINES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. SINGAPORE THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 136. SINGAPORE THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 137. SINGAPORE THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 138. SINGAPORE THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2018-2030 (USD MILLION)
  • TABLE 139. SINGAPORE THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
  • TABLE 140. SINGAPORE THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 141. SINGAPORE THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 142. SOUTH KOREA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. SOUTH KOREA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 144. SOUTH KOREA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 145. SOUTH KOREA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2018-2030 (USD MILLION)
  • TABLE 146. SOUTH KOREA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
  • TABLE 147. SOUTH KOREA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 148. SOUTH KOREA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 149. TAIWAN THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 150. TAIWAN THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 151. TAIWAN THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 152. TAIWAN THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2018-2030 (USD MILLION)
  • TABLE 153. TAIWAN THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
  • TABLE 154. TAIWAN THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 155. TAIWAN THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 156. THAILAND THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 157. THAILAND THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 158. THAILAND THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 159. THAILAND THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2018-2030 (USD MILLION)
  • TABLE 160. THAILAND THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
  • TABLE 161. THAILAND THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 162. THAILAND THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 163. VIETNAM THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 164. VIETNAM THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 165. VIETNAM THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 166. VIETNAM THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2018-2030 (USD MILLION)
  • TABLE 167. VIETNAM THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
  • TABLE 168. VIETNAM THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 169. VIETNAM THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 170. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2018-2030 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 178. DENMARK THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 179. DENMARK THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 180. DENMARK THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 181. DENMARK THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2018-2030 (USD MILLION)
  • TABLE 182. DENMARK THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
  • TABLE 183. DENMARK THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 184. DENMARK THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 185. EGYPT THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 186. EGYPT THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 187. EGYPT THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 188. EGYPT THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2018-2030 (USD MILLION)
  • TABLE 189. EGYPT THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
  • TABLE 190. EGYPT THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 191. EGYPT THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 192. FINLAND THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 193. FINLAND THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 194. FINLAND THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 195. FINLAND THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2018-2030 (USD MILLION)
  • TABLE 196. FINLAND THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
  • TABLE 197. FINLAND THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 198. FINLAND THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 199. FRANCE THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 200. FRANCE THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 201. FRANCE THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 202. FRANCE THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2018-2030 (USD MILLION)
  • TABLE 203. FRANCE THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
  • TABLE 204. FRANCE THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 205. FRANCE THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 206. GERMANY THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 207. GERMANY THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 208. GERMANY THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 209. GERMANY THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2018-2030 (USD MILLION)
  • TABLE 210. GERMANY THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
  • TABLE 211. GERMANY THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 212. GERMANY THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 213. ISRAEL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 214. ISRAEL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 215. ISRAEL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 216. ISRAEL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2018-2030 (USD MILLION)
  • TABLE 217. ISRAEL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
  • TABLE 218. ISRAEL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 219. ISRAEL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 220. ITALY THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 221. ITALY THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 222. ITALY THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 223. ITALY THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2018-2030 (USD MILLION)
  • TABLE 224. ITALY THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
  • TABLE 225. ITALY THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 226. ITALY THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 227. NETHERLANDS THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 228. NETHERLANDS THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 229. NETHERLANDS THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 230. NETHERLANDS THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2018-2030 (USD MILLION)
  • TABLE 231. NETHERLANDS THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
  • TABLE 232. NETHERLANDS THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 233. NETHERLANDS THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 234. NIGERIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 235. NIGERIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 236. NIGERIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 237. NIGERIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2018-2030 (USD MILLION)
  • TABLE 238. NIGERIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
  • TABLE 239. NIGERIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 240. NIGERIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 241. NORWAY THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 242. NORWAY THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 243. NORWAY THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 244. NORWAY THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2018-2030 (USD MILLION)
  • TABLE 245. NORWAY THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
  • TABLE 246. NORWAY THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 247. NORWAY THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 248. POLAND THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 249. POLAND THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 250. POLAND THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 251. POLAND THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2018-2030 (USD MILLION)
  • TABLE 252. POLAND THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
  • TABLE 253. POLAND THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 254. POLAND THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 255. QATAR THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 256. QATAR THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 257. QATAR THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 258. QATAR THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2018-2030 (USD MILLION)
  • TABLE 259. QATAR THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
  • TABLE 260. QATAR THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 261. QATAR THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 262. RUSSIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 263. RUSSIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 264. RUSSIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 265. RUSSIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2018-2030 (USD MILLION)
  • TABLE 266. RUSSIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
  • TABLE 267. RUSSIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 268. RUSSIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 269. SAUDI ARABIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 270. SAUDI ARABIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 271. SAUDI ARABIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 272. SAUDI ARABIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2018-2030 (USD MILLION)
  • TABLE 273. SAUDI ARABIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
  • TABLE 274. SAUDI ARABIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 275. SAUDI ARABIA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 276. SOUTH AFRICA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 277. SOUTH AFRICA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 278. SOUTH AFRICA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 279. SOUTH AFRICA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2018-2030 (USD MILLION)
  • TABLE 280. SOUTH AFRICA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
  • TABLE 281. SOUTH AFRICA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 282. SOUTH AFRICA THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 283. SPAIN THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 284. SPAIN THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 285. SPAIN THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 286. SPAIN THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2018-2030 (USD MILLION)
  • TABLE 287. SPAIN THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
  • TABLE 288. SPAIN THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 289. SPAIN THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 290. SWEDEN THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 291. SWEDEN THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 292. SWEDEN THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 293. SWEDEN THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2018-2030 (USD MILLION)
  • TABLE 294. SWEDEN THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
  • TABLE 295. SWEDEN THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 296. SWEDEN THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 297. SWITZERLAND THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 298. SWITZERLAND THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 299. SWITZERLAND THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 300. SWITZERLAND THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2018-2030 (USD MILLION)
  • TABLE 301. SWITZERLAND THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
  • TABLE 302. SWITZERLAND THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 303. SWITZERLAND THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 304. TURKEY THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 305. TURKEY THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 306. TURKEY THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 307. TURKEY THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2018-2030 (USD MILLION)
  • TABLE 308. TURKEY THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
  • TABLE 309. TURKEY THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 310. TURKEY THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 311. UNITED ARAB EMIRATES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 312. UNITED ARAB EMIRATES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 313. UNITED ARAB EMIRATES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 314. UNITED ARAB EMIRATES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2018-2030 (USD MILLION)
  • TABLE 315. UNITED ARAB EMIRATES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
  • TABLE 316. UNITED ARAB EMIRATES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 317. UNITED ARAB EMIRATES THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 318. UNITED KINGDOM THERAPEUTIC DRUG MONITORING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 319. UNITED KINGDOM THERAPEUTIC DRUG MONITORING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 320. UNITED KINGDOM THERAPEUTIC DRUG MONITORING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 321. UNITED KINGDOM THERAPEUTIC DRUG MONITORING MARKET SIZE, BY CHROMATOGRAPHY-MS, 2018-2030 (USD MILLION)
  • TABLE 322. UNITED KINGDOM THERAPEUTIC DRUG MONITORING MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
  • TABLE 323. UNITED KINGDOM THERAPEUTIC DRUG MONITORING MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 324. UNITED KINGDOM THERAPEUTIC DRUG MONITORING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 325. THERAPEUTIC DRUG MONITORING MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 326. THERAP
目次
Product Code: MRR-A77F2EE7AB57

The Global Therapeutic Drug Monitoring Market is forecasted to grow significantly, with a projected USD 3,790.11 million in 2023 at a CAGR of 16.02% and expected to reach a staggering USD 10,784.57 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Therapeutic Drug Monitoring Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Therapeutic Drug Monitoring Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Product, market is studied across Consumables, Data Management Services, and Equipment. The Equipment is further studied across Chromatography & MS Detectors, Clinical Chemistry Analyzers, and Immunoassay Analyzers. The Consumables commanded largest market share of 48.10% in 2022, followed by Equipment.

Based on Technology, market is studied across Chromatography-MS, Immunoassays, and Proteomic Technologies. The Chromatography-MS is further studied across GC-MS and LC-MS. The Immunoassays is further studied across Chemiluminescence Immunoassays, Colorimetric Immunoassays, Fluorescence Immunoassays, and Radioimmunoassays. The Immunoassays commanded largest market share of 57.53% in 2022, followed by Chromatography-MS.

Based on Drug Class, market is studied across Antiarrhythmic Drugs, Antibiotic Drugs, Antiepileptic Drugs, Bronchodilator Drugs, Immunosuppressant Drugs, and Psychoactive Drugs. The Antibiotic Drugs commanded largest market share of 23.60% in 2022, followed by Immunosuppressant Drugs.

Based on End-User, market is studied across Hospital Labs and Private Labs. The Private Labs commanded largest market share of 53.46% in 2022, followed by Hospital Labs.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa commanded largest market share of 39.48% in 2022, followed by Americas.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Therapeutic Drug Monitoring Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Therapeutic Drug Monitoring Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Therapeutic Drug Monitoring Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Therapeutic Drug Monitoring Market?

4. What is the competitive strategic window for opportunities in the Global Therapeutic Drug Monitoring Market?

5. What are the technology trends and regulatory frameworks in the Global Therapeutic Drug Monitoring Market?

6. What is the market share of the leading vendors in the Global Therapeutic Drug Monitoring Market?

7. What modes and strategic moves are considered suitable for entering the Global Therapeutic Drug Monitoring Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Therapeutic Drug Monitoring Market, by Product, 2022 vs 2030
  • 4.3. Therapeutic Drug Monitoring Market, by Technology, 2022 vs 2030
  • 4.4. Therapeutic Drug Monitoring Market, by Drug Class, 2022 vs 2030
  • 4.5. Therapeutic Drug Monitoring Market, by End-User, 2022 vs 2030
  • 4.6. Therapeutic Drug Monitoring Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increased Demand for Personalized Medicine
      • 5.1.1.2. Rising Adoption of Therapeutic Drug Monitoring Across Various Therapeutic Fields
      • 5.1.1.3. Growing Use and Importance in Patients with Solid Organ Transplantation
    • 5.1.2. Restraints
      • 5.1.2.1. Inadequate Reimbursement Policies
      • 5.1.2.2. Need of High Capital Investments
    • 5.1.3. Opportunities
      • 5.1.3.1. Future Perspectives of Therapeutic Drug Monitoring in Developing Nations
      • 5.1.3.2. Developments in Immunoassay and Other Therapeutic Drug Monitoring Technologies
    • 5.1.4. Challenges
      • 5.1.4.1. Clinical Challenges and Limited Availability of Skilled Laboratory Technicians
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Therapeutic Drug Monitoring Market, by Product

  • 6.1. Introduction
  • 6.2. Consumables
  • 6.3. Data Management Services
  • 6.4. Equipment
    • 6.4.1. Chromatography & MS Detectors
    • 6.4.2. Clinical Chemistry Analyzers
    • 6.4.3. Immunoassay Analyzers

7. Therapeutic Drug Monitoring Market, by Technology

  • 7.1. Introduction
  • 7.2. Chromatography-MS
    • 7.2.1. GC-MS
    • 7.2.2. LC-MS
  • 7.3. Immunoassays
    • 7.3.1. Chemiluminescence Immunoassays
    • 7.3.2. Colorimetric Immunoassays
    • 7.3.3. Fluorescence Immunoassays
    • 7.3.4. Radioimmunoassays
  • 7.4. Proteomic Technologies

8. Therapeutic Drug Monitoring Market, by Drug Class

  • 8.1. Introduction
  • 8.2. Antiarrhythmic Drugs
  • 8.3. Antibiotic Drugs
  • 8.4. Antiepileptic Drugs
  • 8.5. Bronchodilator Drugs
  • 8.6. Immunosuppressant Drugs
  • 8.7. Psychoactive Drugs

9. Therapeutic Drug Monitoring Market, by End-User

  • 9.1. Introduction
  • 9.2. Hospital Labs
  • 9.3. Private Labs

10. Americas Therapeutic Drug Monitoring Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Therapeutic Drug Monitoring Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Therapeutic Drug Monitoring Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
  • 13.2. Market Share Analysis, By Key Player
  • 13.3. Competitive Scenario Analysis, By Key Player
    • 13.3.1. Agreement, Collaboration, & Partnership
      • 13.3.1.1. Capitainer announces collaboration with AstraZeneca.
      • 13.3.1.2. AegirBio AB enters into an agreement with Atlas Special Opportunities, LLC regarding convertible bonds of SEK 55 million with attached warrants to intensify investments in i.a. TDM and saliva sampling.
      • 13.3.1.3. Clinical LC-MS methods for therapeutic drug monitoring analysis.
      • 13.3.1.4. Beckman Coulter and Saladax Biomedical Team Up on Antipsychotic Therapeutic Drug Monitoring.
    • 13.3.2. New Product Launch & Enhancement
      • 13.3.2.1. Bio-Rad Extends Range of Anti-Idiotypic Antibodies for Bioanalysis and Drug Monitoring.
    • 13.3.3. Investment & Funding
      • 13.3.3.1. Novo Holdings invests in proteomics technology company, Evosep.
      • 13.3.3.2. Ampersand Capital Partners Invests in Syft Technologies, Leading SIFT-MS Solutions Provider.
    • 13.3.4. Award, Recognition, & Expansion
      • 13.3.4.1. Boditech Med has obtained the export license of four TDM products.
      • 13.3.4.2. Pace Obtains EPA Approval on Method for Detecting Dioxins and Dibenzofurans Through GC-MS/MS Technology.

14. List of Company Mentioned

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing